Neuritic pathology as a correlate of synaptic loss in dementia with Lewy bodies

American Journal of Alzheimer's Disease and other Dementias

Volumn 23, Issue 1, 2008, Pages 97-102

  Revuelta, Gonzalo J ^a   Rosso, Andrea ^a   Lippa, Carol F ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Braak stage; Dementia with Lewy bodies; Synapse; Synaptic loss; Tau; synuclein; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; SYNAPTOPHYSIN; ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN;

ADULT; AGED; ARTICLE; AUTOANALYSIS; COGNITION; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LEWY BODY; MALE; NERVE DEGENERATION; NEURITE; QUANTITATIVE ANALYSIS; SYNAPSE; METABOLISM; MIDDLE AGED; PATHOLOGY; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; AMYLOID BETA-PROTEIN PRECURSOR; FEMALE; HIPPOCAMPUS; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; NERVE DEGENERATION; SENILE PLAQUES; SYNAPSES;

EID: 42949093121     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317507310565     Document Type: Article

References (21)

1. McKeith IG, Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996 ; 47: 1113-1124.
2. Marui W., Iseki E., Kato M., Akatsu H., Kosaka K. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease. Acta Neuropathol. 2004 ; 108: 121-128.
3. Merdes AR, Hansen LA, Jeste DV, et al. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 2003 ; 60: 1586-1590.
4. McKeith IG, Dickson DW, Lowe J., et al. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology. 2005 ; 65: 1864-1872.
5. Hamos JE, DeGennaro LJ, Drachman DA Synaptic loss in Alzheimer's disease and other dementias. Neurology. 1989 ; 39: 355-361.
6. Terry RD, Masliah E., Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991 ; 30: 572-580.
7. Hansen LA, Daniel SE, Wilcock GK, Love S. Frontal cortical synapthophysin in Lewy body diseases: relation to Alzheimer's disease and dementia. J Neurol Neurosurg Psychiatry. 1998 ; 64: 653-656.
8. Brown DF, Risser RC, Bigio EH, et al. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J Neuropathol Exp Neurol. 1998 ; 57: 955-960.
9. Hamos JE, DeGennaro LJ, Drachman DA Synaptic loss in Alzheimer's disease and other dementias. Neurology. 1989 ; 39: 355-361.
10. Lippa CF, Hamos JE, Pulaski-Salo D., DeGennaro LJ, Drachman DA Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging. 1992 ; 13: 405-411.
11. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (Berl). 2006 ; 112: 389-404.
12. Brown DF, Dababo MA, Bigio EH, et al. Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol. 1998 ; 57: 39-46.
13. Popescu A., Lippa CF, Lee VM, Trojanowski JQ Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Arch Neurol. 2004 ; 61: 1915-1919.
14. Lippa CF, Pulaski-Salo D., Dickson DW, Smith TW Alzheimer's disease, Lewy body disease and aging: a comparative study of the perforant pathway. J Neurol Sci. 1997 ; 147: 161-166.
15. Samuel W., Alford M., Hofstetter R., Hansen L. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol. 1997 ; 56: 499-508.
16. Kowalska A. The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease. Neurol Neurochir Pol. 2004 ; 38: 405-411.
17. Klucken J., McLean PJ, Gomez-Tortosa E., Ingelsson M., Hyman BT Neuritic alteration and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies. Neurochem Res. 2003 ; 28: 1683-1691.
18. Hashimoto M., Masliah E. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies. Neurochem Res. 2003 ; 28: 1743-1756.
19. Masliah E., Mallory M., DeTeresa R., Alford M., Hansen L. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res. 1993 ; 617: 258-266.
20. Coleman P., Federoff H., Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology. 2004 ; 63: 1155-1162.
21. Deramecourt V., Bombois S., Maurage CA, et al. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol. 2006 ; 65: 278-288.